Publicaciones en colaboración con investigadores/as de Hospital Universitario Son Espases (12)

2017

  1. Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib

    Scientific Reports, Vol. 7

2015

  1. Pazopanib in pretreated advanced neuroendocrine tumors: A phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)

    Annals of Oncology, Vol. 26, Núm. 9, pp. 1987-1993

2011

  1. Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: A prospective study in a clinically-relevant spectrum of patients

    European Journal of Epidemiology, Vol. 26, Núm. 3, pp. 229-236

2010

  1. Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours

    European Journal of Cancer Care, Vol. 19, Núm. 5, pp. 648-655

2009

  1. Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma

    Environmental and Molecular Mutagenesis, Vol. 50, Núm. 5, pp. 421-430

2007

  1. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer

    Journal of Epidemiology and Community Health, Vol. 61, Núm. 7, pp. 641-649

2004

  1. Prospective randomised phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer

    Clinical Lung Cancer, Vol. 6, Núm. 3, pp. 175-183

2003

  1. Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer: A Spanish Lung Cancer Group phase II study

    Annals of Oncology, Vol. 14, Núm. 10, pp. 1549-1554

2000

  1. Occupation and pancreatic cancer in Spain: A case-control study based on job titles

    International Journal of Epidemiology, Vol. 29, Núm. 6, pp. 1004-1013

  2. Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology

    European Journal of Epidemiology, Vol. 16, Núm. 6, pp. 533-541

1999

  1. Medical conditions in patients with pancreatic and biliary diseases: Validity and agreement between data from questionnaires and medical records

    Digestive Diseases and Sciences, Vol. 44, Núm. 12, pp. 2469-2477

1995

  1. Concordancia entre la información facilitada por el paciente y un familiar sobre antecedentes, patológicos, consumo de tabaco, de alcohol, de café, y dieta en el cáncer de páncreas exocrino y del sistema biliar extrahepático

    Gaceta Sanitaria, Vol. 9, Núm. 51, pp. 334-342